CVKD - Company ID 0001937993
The table below shows Cadrenal Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.39M | $2.31M | $3.86M | $5.00M | $7.34M | $4.36M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $5.58M |
| $2.86M |
| $4.08M |
| $5.97M |
| $7.94M |
| $4.67M |
| Property, plant & equipment | $2.67K | $4.62K | $5.73K | $4.28K | $4.68K | $814.00 |
| Goodwill | - | - | - | - | - | - |
| Total assets | $5.59M | $2.86M | $4.09M | $5.98M | $7.95M | $4.68M |
| Accounts payable | $871.91K | $824.81K | $614.13K | $895.61K | $1.28M | $496.82K |
| Total current liabilities | $1.50M | $1.06M | $1.35M | $1.68M | $1.84M | $1.27M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.50M | $1.06M | $1.35M | $1.68M | $1.84M | $1.27M |
| Retained earnings | -$44.78M | -$41.46M | -$35.92M | -$33.24M | -$29.57M | -$21.54M |
| Total equity | $4.09M | $1.80M | $2.73M | $4.30M | $6.11M | $3.41M |